call (314) 741-0911

Partnering with You to Move Medicine Forward.

Who We Are

St. Louis Heart and Vascular is a proven and trusted resource for the conduct of complex Phase II-IV studies in subjects with acute coronary heart disease, atrial fibrilation, coronary heart disease and heart failure. The research staff is proficient in all standard procedures and is highly experienced in the conduct of specialized and complex study designs, which include cardiac monitoring (TQT/ QTc), and intensive pharmacokinetic sampling. The site’s team of physicians have developed a solid infrastructure for identifying quality research subjects throughout their practice, resulting in meeting and exceeding enrollment targets on the vast majority of trials conducted.

Bridgeton Office
Gil Vardi, MD

Dr. Gil Vardi of St. Louis Heart & Vascular is the first cardiologist in the world to implant the BAT-wire Barostim Neo CVRX device.

Why Participate in Clinical Research?

By volunteering to participate in a clinical trial, you will contribute to the advancement of medical knowledge and innovation. Volunteers play a direct role in shaping the future of healthcare and support the advancement of effective healthcare solutions. Your participation can lead to medical breakthroughs benefiting not only you, but the global healthcare system.

During the trial, you’ll receive individualized care, ongoing health monitoring / assessments, and comprehensive medical evaluations. Your participation is critical to the improvement of both individual and pubic health - and - medical advancements.

Article Icon

Gil Vardi MD First Cardiologist to Implant BAT-wire Barostim Neo CVRX Device

Gil Vardi MD has become the first cardiologist in the world to implant the BAT-wire Barostim Neo CVRX device. The procedure was performed at Premier Surgical Center on the St. Louis Heart and Vascular (SLHV) campus in Bridgeton, Missouri. The Barostim device includes a pulse generator implanted below the collarbone with a lead attached to […]

Read More
Article Icon

St. Louis Heart and Vascular’s Contribution to the Xarelto Clinical Trial (2013-2016)

From 2013 to 2016, St. Louis Heart and Vascular played a crucial role in one of the largest and most important clinical trials in the field of cardiology: the Xarelto (rivaroxaban) clinical trial. This groundbreaking study sought to determine the efficacy of Xarelto as an anticoagulant for patients suffering from coronary artery disease (CAD), peripheral […]

Read More
Article Icon

St. Louis Heart and Vascular’s Groundbreaking Journey in the BeAT-HF Clinical Trial (2016-2023)

St. Louis Heart and Vascular (SLHV) has been at the forefront of cardiovascular innovation, playing a pivotal role in the BeAT-HF (Biomarker-Enhanced Assessment of Targeted Heart Failure) clinical trial, conducted from 2016 to 2023. SLHV has contributed to advancing heart failure treatment with the goal of offering new hope for patients struggling with this debilitating […]

Read More

Associations & Organizations